NAD+ injection is one of the biggest names in the longevity-clinic world right now — and it sits on an unusual foundation: the underlying science is genuinely solid, but the specific thing being sold (injecting it) is where the evidence thins out. Both halves of that sentence matter, so this page keeps them separate.
In plain terms: NAD+ is real, important, and does decline with age. Whether *injecting* it does anything special is a much smaller, shakier body of evidence than the marketing implies.
What NAD+ actually is
NAD+ (nicotinamide adenine dinucleotide) is an essential coenzyme — a helper molecule your cells cannot run without. It's a redox cofactor for a huge number of metabolic enzymes, and it's the fuel for two important jobs: it's the substrate for PARPs (which repair DNA) and for sirtuins, the enzymes often called "longevity" regulators2. Through those roles NAD+ touches metabolism, DNA repair, gene expression, and stress responses.
Here's the part that's well established: NAD+ levels decline systemically with age, across many tissues, and that decline is associated with essentially all the hallmarks of aging1. In animal models, restoring NAD+ delays or even reverses several age-related problems1. That is a real, active field of science — not wellness folklore.
Why people inject it
If NAD+ falls with age and topping it up helps animals, the logic goes, why not put it back? Injections and IV drips are marketed as the most "direct" way — bypassing the gut to deliver NAD+ (or its precursors) straight into circulation. The pitch is energy, "cellular repair," and slowing aging. The pitch is plausible. The question is what the human evidence actually supports.
What the evidence actually shows
This is the crux, and it's worth being precise: the strong human data is for oral precursors, not for injected NAD+ itself.
| Study | What it tested | What it found | Year |
|---|---|---|---|
| Irie et al.3 | Single oral NMN (100–500 mg), 10 healthy men | Safe; NMN was metabolized as expected | 2020 |
| Okabe et al.2 | Oral NMN in healthy subjects | Safe, and efficiently raised blood NAD+ | 2022 |
| Katayoshi et al.4 | 12-week RCT, 125 mg NMN twice daily, 36 adults | Raised an NAD+ metabolite; placebo-controlled | 2023 |
| Yamaguchi et al.5 | 8-week oral NMN, middle-aged men | Effects on metabolism, sleep, and NAD+ biosynthesis | 2024 |
The pattern is consistent and genuinely positive as far as it goes: oral NMN and NR raise blood NAD+ and are well tolerated in short trials24. But two things are missing, and they're the things the injection hype glosses over.
The honest gaps
- "Raises NAD+" is not "slows aging." These trials measure biomarkers — blood NAD+ levels, arterial stiffness, metabolic markers — over weeks, not lifespan or hard clinical outcomes. As one of the trials themselves puts it, evidence of NAD+ supplementation's real effect on humans "is still scarce"2. Raising a number is encouraging; proving it makes you age slower is a different, much harder claim that no human trial has delivered.
- The strong data is for pills, not injections. Almost all the rigorous human work is on oral NMN and NR1. Direct injected or IV NAD+ — the clinic product — has very little controlled trial evidence of its own. And there's an awkward implication: if inexpensive oral precursors already raise blood NAD+2, the specific case for *injecting* it needs its own proof, which isn't really there yet.
Side effects and safety
For the oral precursors, short human trials have reported good tolerability35. For IV NAD+ specifically, the commonly described experience is flushing, nausea, or chest tightness during the infusion if it's run quickly — and, importantly, these drips are often given in unregulated wellness settings where product quality, dose, and sterility aren't guaranteed. Long-term safety of injected NAD+ has not been well characterized. None of this is medical advice; it's the evidence context.
The honest bottom line
NAD+ is a legitimately important molecule with a real, age-related decline behind it — that part deserves the attention it gets. But the injection specifically is running ahead of its evidence: the solid human trials are on oral precursors, they show NAD+ *levels* rising rather than aging *slowing*, and the injected form is the least-studied, least-regulated version of the idea. Interesting biology, genuinely — just not the settled anti-aging cure the marketing suggests. Educational overview only, not medical advice; see also what are research peptides.